|
MED6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.084200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.165400E-01 |
| Normal-vs-Stage2 |
4.082800E-01 |
| Normal-vs-Stage3 |
3.290100E-02 |
| Normal-vs-Stage4 |
7.943800E-02 |
| Stage1-vs-Stage2 |
9.821000E-01 |
| Stage1-vs-Stage3 |
1.095050E-01 |
| Stage1-vs-Stage4 |
3.990200E-01 |
| Stage2-vs-Stage3 |
1.612050E-01 |
| Stage2-vs-Stage4 |
4.061200E-01 |
| Stage3-vs-Stage4 |
6.979400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.104300E-02 |
| Normal-vs-AfricanAmerican |
1.873600E-01 |
| Normal-vs-Asian |
2.936200E-01 |
| Caucasian-vs-AfricanAmerican |
7.893400E-01 |
| Caucasian-vs-Asian |
4.459800E-01 |
| AfricanAmerican-vs-Asian |
4.220600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.172040E-01 |
| Normal-vs-Female |
8.436400E-03 |
| Male-vs-Female |
7.706200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.351790E-01 |
| Normal-vs-Extreme_Weight |
2.382800E-01 |
| Normal-vs-Obese |
3.200000E-02 |
| Normal-vs-Extreme_Obese |
2.747200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.592200E-01 |
| Normal_Weight-vs-Obese |
6.527800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.206630E-01 |
| Extreme_Weight-vs-Obese |
2.376600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.642990E-01 |
| Obese-vs-Extreme_Obese |
7.653800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.785590E-02 |
| Normal-vs-Age(41-60Yrs) |
1.915820E-03 |
| Normal-vs-Age(61-80Yrs) |
7.405600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.285800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.137050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.044100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.463500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.578900E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.536380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.670200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.045700E-02 |
| Normal-VS-Type2 PRCC |
9.794800E-01 |
| Normal-VS-KIRP CIMP |
1.461650E-02 |
| Normal-VS-Unclassified PRCC |
2.551600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.159800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.239600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.236600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.378370E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.678400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.924000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.254400E-01 |
| Normal-vs-N1 |
3.958000E-03 |
| Normal-vs-N2 |
3.358800E-01 |
| N0-vs-N1 |
5.402000E-03 |
| N0-vs-N2 |
4.052000E-01 |
| N1-vs-N2 |
1.021200E-01 |
|
|
